4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001144204-13-045326
Chief Financial Officer acquired 245,450 shares (option exercise)
- Chief Financial Officer acquired 114,000 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Buck Paul · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-08-12 | Conversion : show line 1 in the form | +114,000 | $0.25 | $28,500 | 236,083 | D |
| 2013-08-12 | Exercise or conversion : show line 2 in the form | +245,450 | $0.25 | $61,363 | 481,533 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2013-08-09 | Purchase : show line 3 in the form Convertible Promissory Note | +0 | D | |
| 2013-08-12 | Conversion : show line 4 in the form Convertible Promissory Note | +0 | D | |
| 2013-08-12 | Exercise or conversion : show line 5 in the form Convertible Promissory Note | +0 | 0 | D |
Loading xslF345X03/v352923_4.xml…